What does DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE do?

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is a specialist medical practice in Grimbergen. Private Limited, started on 12 February 2009, 1 establishment.

What is the address of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE?

The registered office of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is located at Jozef Van Elewijckstraat 75, 1853 Grimbergen.

Is DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE still active?

Yes. According to the CBE (2 October 2026) DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is active, legal situation “Normale toestand”, started on 12 February 2009.

Is DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE registered on Peppol?

Yes, DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is registered on the Peppol network with ID 0208:0809765106.

What is the enterprise number of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE?

The enterprise number of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is BE0809765106.

When was DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE founded?

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE was founded on 12 February 2009.

Who are the directors of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE?

According to the 2025 annual accounts, the directors of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE are: Veerle Delvaux.

Is DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE make in 2025?

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE posted a profit after taxes of € 138,303 in financial year 2025.

What is the revenue of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE?

As a small company, DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 200,621.

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE (Private Limited)

Dossier DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE, printed on 2 October 2026 from databakkes.be/en/0809765106/dr-veerle-delvaux-anatomo-pathologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE from Grimbergen, company number BE0809765106, closed financial year 2025 with a result of € 138,303 after tax. For that financial year DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE recorded a gross margin of € 200,621 and equity of € 610,440. Compared with financial year 2024, the result moved from € 130,035 to € 138,303. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 6, 2026.

What it is worth Growing

€ 610,440

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 138,303

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 493,366

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 74,203 paid out

54 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 5,941

▼ 47% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 8,262

▼ 7% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 687

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,645

▲ 8% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 112,327 Gross margin 2022: € 112,327 First fiscal year in the series	€ 147,389 Gross margin 2023: € 147,389 ▲ 31% vs 2022 (€ 112,327) Favourable step	€ 192,931 Gross margin 2024: € 192,931 ▲ 31% vs 2023 (€ 147,389) Favourable step	€ 200,621 Gross margin 2025: € 200,621 ▲ 4% vs 2024 (€ 192,931) Favourable step	▲ 4%
Profit after taxes	€ 75,899 Profit after taxes 2022: € 75,899 First fiscal year in the series	€ 98,463 Profit after taxes 2023: € 98,463 ▲ 30% vs 2022 (€ 75,899) Favourable step	€ 130,035 Profit after taxes 2024: € 130,035 ▲ 32% vs 2023 (€ 98,463) Favourable step	€ 138,303 Profit after taxes 2025: € 138,303 ▲ 6% vs 2024 (€ 130,035) Favourable step	▲ 6%
Equity	€ 456,851 Equity 2022: € 456,851 First fiscal year in the series	€ 467,198 Equity 2023: € 467,198 ▲ 2% vs 2022 (€ 456,851) Favourable step	€ 546,339 Equity 2024: € 546,339 ▲ 17% vs 2023 (€ 467,198) Favourable step	€ 610,440 Equity 2025: € 610,440 ▲ 12% vs 2024 (€ 546,339) Favourable step	▲ 12%
Total debts	€ 17,153 Total debts 2022: € 17,153 First fiscal year in the series	€ 22,045 Total debts 2023: € 22,045 ▲ 29% vs 2022 (€ 17,153) Unfavourable step	€ 33,790 Total debts 2024: € 33,790 ▲ 53% vs 2023 (€ 22,045) Unfavourable step	€ 34,681 Total debts 2025: € 34,681 ▲ 3% vs 2024 (€ 33,790) Unfavourable step	▲ 3%
Cash	€ 365,084 Cash 2022: € 365,084 First fiscal year in the series	€ 344,067 Cash 2023: € 344,067 ▼ 6% vs 2022 (€ 365,084) Unfavourable step	€ 433,112 Cash 2024: € 433,112 ▲ 26% vs 2023 (€ 344,067) Favourable step	€ 493,366 Cash 2025: € 493,366 ▲ 14% vs 2024 (€ 433,112) Favourable step	▲ 14%
Retained profit	€ 444,451 Retained profit 2022: € 444,451 First fiscal year in the series	€ 454,798 Retained profit 2023: € 454,798 ▲ 2% vs 2022 (€ 444,451) Favourable step	€ 533,939 Retained profit 2024: € 533,939 ▲ 17% vs 2023 (€ 454,798) Favourable step	€ 598,040 Retained profit 2025: € 598,040 ▲ 12% vs 2024 (€ 533,939) Favourable step	▲ 12%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 88,116 Dividend 2023: € 88,116 ▲ € 87,316 vs 2022 (€ 800) Unchanged	€ 50,894 Dividend 2024: € 50,894 ▼ 42% vs 2023 (€ 88,116) Unchanged	€ 74,203 Dividend 2025: € 74,203 ▲ 46% vs 2024 (€ 50,894) Unchanged	▲ 46%
Bank debt	€ 8,796 Bank debt 2022: € 8,796 First fiscal year in the series	€ 8,849 Bank debt 2023: € 8,849 ▲ 1% vs 2022 (€ 8,796) Unfavourable step	€ 8,920 Bank debt 2024: € 8,920 ▲ 1% vs 2023 (€ 8,849) Unfavourable step	€ 8,262 Bank debt 2025: € 8,262 ▼ 7% vs 2024 (€ 8,920) Favourable step	▼ 7%
Balance sheet total	€ 474,005 Balance sheet total 2022: € 474,005 First fiscal year in the series	€ 489,243 Balance sheet total 2023: € 489,243 ▲ 3% vs 2022 (€ 474,005) Unchanged	€ 580,129 Balance sheet total 2024: € 580,129 ▲ 19% vs 2023 (€ 489,243) Unchanged	€ 645,121 Balance sheet total 2025: € 645,121 ▲ 11% vs 2024 (€ 580,129) Unchanged	▲ 11%

Key figures of DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE?

What happened at DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 6, 2026 New annual accounts for financial year 2025: profit of € 138,303 (▲ 6% vs 2024). Source: NBB ↗
Feb 12, 2009 Start of the company according to the CBE. KBO
Feb 2, 2009 New establishment in Grimbergen. KBO
2009 Veerle Delvaux became a director. NBB

In short

From € 75,899 profit in 2022 to € 138,303 profit in 2025.

Paid € 183,681 in corporate taxes since 2022.

Best year ever: 2025, with € 138,303 profit.

Paid out € 214,013 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE? We notify you, reason included.

Follow DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Veerle Delvaux

DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE

Behind DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE is Veerle Delvaux.

See the full network in the app

Directors

According to the 2025 annual accounts

Veerle Delvaux

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Jozef Van Elewijckstraat 75

1853 Grimbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0809.765.106
VAT number: BE 0809.765.106
Registered office: Jozef Van Elewijckstraat 75, 1853 Grimbergen
Names & denominations: DR. VEERLE DELVAUX,ANATOMO-PATHOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 February 2009
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗